InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Nicholson Nur, Chief Technical Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 22 filings have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €1.1m. History available since 21 January 2022. The latest transaction was disclosed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Nicholson Nur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报22 总计
116,338 股Common StockSEC:0001193125-26-224604:0
45,220 股0Common StockSEC:0001492422-26-000074:0
7,725 股@ US$21.76549.5% 占其流量Common StockSEC:0001492422-26-000056:0
2,203 股@ US$19.79292.5% 占其流量Common StockSEC:0001492422-26-000040:0
2,618 股@ US$22.18723.3% 占其流量Common StockSEC:0001492422-26-000027:0
825 股@ US$29.52361.8% 占其流量Common StockSEC:0001127602-25-002383:0
3,948 股@ US$30.42559.0% 占其流量Common StockSEC:0001127602-25-001841:0
2,145 股@ US$29.95824.9% 占其流量Common StockSEC:0001127602-25-001625:0
36,426 股0Common StockSEC:0001127602-25-001625:1
2,632 股@ US$28.70215.8% 占其流量Common StockSEC:0001127602-25-001201:0
7,768 股@ US$57.30731.8% 占其流量Common StockSEC:0001127602-24-010127:0
835 股@ US$64.13823.9% 占其流量Common StockSEC:0001127602-24-002746:0
2,593 股@ US$64.99612.1% 占其流量Common StockSEC:0001127602-24-001953:0
19,508 股0Common StockSEC:0001127602-24-001437:0
9,719 股@ US$29.7668.5% 占其流量Common StockSEC:0001127602-23-024445:0
9,886 股0Common StockSEC:0000899243-23-005786:0
551 股@ US$52.772.1% 占其流量Common StockSEC:0001127602-23-002687:0
2,034 股@ US$52.057.6% 占其流量Common StockSEC:0001127602-23-002133:0
1,875 股0Common StockSEC:0001127602-23-001499:0
22,580 股0Common StockSEC:0001127602-23-001499:1
650 股@ US$38.590.0004% mcap50.0% 占其流量Common StockSEC:0001127602-22-002812:0
26,051 股0Common StockSEC:0001127602-22-002062:0
22 条申报中的 22 条
About Nicholson Nur
Nicholson Nur is Chief Technical Officer at Apellis Pharmaceuticals, Inc. (XNAS). He has 22 filings in total, and in the sampled recent filings all transactions are sales, for a total amount of EUR 1,117,681 between 2022-01-25 and 2026-05-14.
